Literature DB >> 11091178

Non-myeloablative stem cell transplants.

J Barrett1, R Childs.   

Abstract

Mesh:

Substances:

Year:  2000        PMID: 11091178     DOI: 10.1046/j.1365-2141.2000.02405.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  10 in total

1.  Impact of irradiation and immunosuppressive agents on immune system homeostasis in rhesus macaques.

Authors:  C Meyer; J Walker; J Dewane; F Engelmann; W Laub; S Pillai; Charles R Thomas; I Messaoudi
Journal:  Clin Exp Immunol       Date:  2015-06-29       Impact factor: 4.330

Review 2.  Advances in haplo-identical stem cell transplantation in adults with high-risk hematological malignancies.

Authors:  Michael J Ricci; Jeffrey A Medin; Ronan S Foley
Journal:  World J Stem Cells       Date:  2014-09-26       Impact factor: 5.326

3.  Treatment of hematological malignancies with nonmyeloablative, HLA-haploidentical bone marrow transplantation and high dose, post-transplantation cyclophosphamide.

Authors:  Ashley T Munchel; Yvette L Kasamon; Ephraim J Fuchs
Journal:  Best Pract Res Clin Haematol       Date:  2011-07-13       Impact factor: 3.020

Review 4.  Treatment of chronic myeloid leukaemia: lessons and challenges.

Authors:  John M Goldman
Journal:  Int J Hematol       Date:  2002-08       Impact factor: 2.490

5.  Transfusion of RhD-incompatible blood components in RhD-negative blood marrow transplant recipients.

Authors:  M Asfour; Aida Narvios; Benjamin Lichtiger
Journal:  MedGenMed       Date:  2004-07-13

Review 6.  Pushing the envelope-nonmyeloablative and reduced intensity preparative regimens for allogeneic hematopoietic transplantation.

Authors:  S R Pingali; R E Champlin
Journal:  Bone Marrow Transplant       Date:  2015-05-18       Impact factor: 5.483

Review 7.  Allogeneic stem cell transplantation for the treatment of advanced solid tumors.

Authors:  Marco Bregni; Massimo Bernardi; Fabio Ciceri; Jacopo Peccatori
Journal:  Springer Semin Immunopathol       Date:  2004-09-11

8.  Current status of hematopoietic cell transplantation for adult patients with hematologic diseases and solid tumors in Japan.

Authors:  Masahiro Imamura; Shigetaka Asano; Mine Harada; Yasuo Ikeda; Koji Kato; Shunichi Kato; Keisei Kawa; Seiji Kojima; Yasuo Morishima; Yoshihisa Morishita; Tatsutoshi Nakahata; Jun Okamura; Shinichiro Okamoto; Shintaro Shiobara; Mitsune Tanimoto; Masahiro Tsuchida; Yoshiko Atsuta; Kazuhito Yamamoto; Junji Tanaka; Nobuyuki Hamajima; Yoshihisa Kodera
Journal:  Int J Hematol       Date:  2006-02       Impact factor: 2.490

9.  JAK2 p.V617F allele burden in myeloproliferative neoplasms one month after allogeneic stem cell transplantation significantly predicts outcome and risk of relapse.

Authors:  Thoralf Lange; Anja Edelmann; Udo Siebolts; Rainer Krahl; Claudia Nehring; Nadja Jäkel; Michael Cross; Jacqueline Maier; Dietger Niederwieser; Claudia Wickenhauser
Journal:  Haematologica       Date:  2013-01-08       Impact factor: 9.941

Review 10.  Non-myeloablative allogeneic hematopoietic stem cell transplantation.

Authors:  Nonniekaye Shelburne; Margaret Bevans
Journal:  Semin Oncol Nurs       Date:  2009-05       Impact factor: 2.315

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.